Among the many notable trends in CT, one of the fastest growing is the coronary CT angiography market, as witnessed at RSNA23
By Melinda Taschetta-Millane
March 07, 2024
The Evolving Computed Tomography Market
Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and…
Read More
An AMA letter sent to Secretary Bacerra outlines ongoing concerns of physicians amidst the cybersecurity incident that has impacted Change Healthcare
March 06, 2024
As Cyberattack Jeopardizes Physician Practices, AMA Demands Action
March 6, 2024 — As the cyber-takedown of Change Healthcare has forced medical practices to go without revenue for a…
Read More
Company’s AI-enabled technology for future heart attack risk assessment accepted into FDA’s TAP Pilot and to be validated in landmark TRANSFORM trial
March 06, 2024
Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System
March 6, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart…
Read More
Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Designation for their ECGvision-TTR Technology
March 06, 2024
Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy
March 6, 2024 — Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of…
Read More
Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
March 06, 2024
Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference
March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from…
Read More
Lantheus announced that the U.S. Food and Drug Administration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
March 06, 2024
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients
March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and…
Read More
Konica Minolta's Exa Platform
By Melinda Taschetta-Millane
March 06, 2024
The Emergence of Cloud-based PACS, and Other Trends
Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital…
Read More
Hal Wolf, president and CEO of HIMSS
March 06, 2024
One on One ... with Hal Wolf, FHIMSS
Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management…
Read More
A look at DAIC's top-viewed content for February 2024
By Melinda Taschetta-Millane
March 05, 2024
A Look at February's Top 10
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being…
Read More
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision
March 05, 2024
SPONSORED CONTENT: Finding the Right Solution
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability…
Read More
NIH-funded observational study shows risk grows sharply with more frequent use
March 05, 2024
Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke
March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke,…
Read More
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow
March 05, 2024
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform
March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring.
March 05, 2024
FIRE1 Completes Enrollment in US Early Feasibility Study of Innovative Remote Heart Failure Monitoring System
March 5, 2024 —  FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-…
Read More
During the upcoming Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends.
March 05, 2024
Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare
March 6, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and…
Read More
First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence
March 01, 2024
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon
March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA)…
Read More
Maternal stress may lead to adverse changes in mental, physical health that impact development of the fetal heart
March 01, 2024
Severe Maternal Grief Associated with Increased Risk of Heart Failure in Child
March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a…
Read More
Sumeet Chugh, MD. Photo by Cedars-Sinai
March 01, 2024
New Studies: AI Captures Electrocardiogram Patterns That Could Signal a Future Sudden Cardiac Arrest
March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict…
Read More
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
February 29, 2024
American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary
February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific…
Read More
On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI."
February 29, 2024
Webinar on Optimizing Structural Heart Workflows to be Rescheduled
PLEASE NOTE: This webinar has been postponed to a later date.  A new date will be posted in the coming days.    On…
Read More
New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases
February 28, 2024
Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients
February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now